Loading insider details...
Latest Form 4 (Sep 11, 2026): Purchase of 19,883 MGX shares, $23.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Purchase | 19,883 | $23.3K |
| Jun 11, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Disposition to Issuer | 17,000 | n/a |
| Jun 11, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Grant/Award | 17,400 | n/a |
| Sep 2, 2025 | Metagenomi, Inc. (MGX) | Grant/Award | 42,000 | n/a |
| Nov 26, 2024 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 17,000 | n/a |